NDC Pharmacologic Class N0000191423 Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 49702-226 | Tivicay | Dolutegravir Sodium | Tablet, Film Coated | Oral | Viiv Healthcare Company | Human Prescription Drug |
| 49702-227 | Tivicay | Dolutegravir Sodium | Tablet, Film Coated | Oral | Viiv Healthcare Company | Human Prescription Drug |
| 49702-228 | Tivicay | Dolutegravir Sodium | Tablet, Film Coated | Oral | Viiv Healthcare Company | Human Prescription Drug |
| 49702-231 | Triumeq | Abacavir Sulfate, Dolutegravir Sodium, Lamivudine | Tablet, Film Coated | Oral | Viiv Healthcare Company | Human Prescription Drug |
| 49702-242 | Juluca | Dolutegravir Sodium And Rilpivirine Hydrochloride | Tablet, Film Coated | Oral | Viiv Healthcare Company | Human Prescription Drug |
| 70518-1487 | Tivicay | Dolutegravir Sodium | Tablet, Film Coated | Oral | Remedyrepack Inc. | Human Prescription Drug |
There are 6 NDC products with the pharmacologic class Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA].